|
|
|
|
LEADER |
01000caa a22002652c 4500 |
001 |
NLM349147698 |
003 |
DE-627 |
005 |
20250304032423.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2022 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.2144/btn-2022-0048
|2 doi
|
028 |
5 |
2 |
|a pubmed25n1163.xml
|
035 |
|
|
|a (DE-627)NLM349147698
|
035 |
|
|
|a (NLM)36401550
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Zeng, Xi
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Removal of nonspecific binding proteins is required in co-immunoprecipitation with nuclear proteins
|
264 |
|
1 |
|c 2022
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 19.12.2022
|
500 |
|
|
|a Date Revised 22.12.2022
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Whether protein samples should be pretreated to remove nonspecific binding proteins in co-immunoprecipitation (CO-IP) is controversial. In this work, nonspecific binding of proteins to agarose beads was found to be greater than that to magnetic beads. The nonspecific binding was increased with the decrease of ion concentrations but reduced by Nonidet P40. Western blot indicated that p65 and β-actin were present as nonspecifically bound protein to the beads. p53 and β-actin were present in the CO-IP precipitates of nuclear proteins but pretreatment cleared the nonspecifically pulled down p53 and β-actin. These data suggest that magnetic beads are better for CO-IP, but preclearing is necessary to minimize false positive regardless of which bead is used, particularly for nuclear proteins
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a NP-40
|
650 |
|
4 |
|a Western blot
|
650 |
|
4 |
|a agarose beads
|
650 |
|
4 |
|a co-immunoprecipitation
|
650 |
|
4 |
|a cytoplasmic and nuclear protein extraction
|
650 |
|
4 |
|a nonspecific binding proteins
|
650 |
|
4 |
|a nuclear proteins
|
650 |
|
4 |
|a osmotic pressure
|
650 |
|
4 |
|a preclear
|
650 |
|
4 |
|a protein–protein interactions
|
650 |
|
7 |
|a Actins
|2 NLM
|
650 |
|
7 |
|a Carrier Proteins
|2 NLM
|
650 |
|
7 |
|a Nuclear Proteins
|2 NLM
|
650 |
|
7 |
|a Tumor Suppressor Protein p53
|2 NLM
|
700 |
1 |
|
|a Zeng, Wei-Hong
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhou, Jun
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Liu, Xiao-Min
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Huang, Guo
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhu, Hong
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Xiao, Shuai
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zeng, Ying
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cao, Deliang
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t BioTechniques
|d 1993
|g 73(2022), 6 vom: 01. Dez., Seite 289-296
|w (DE-627)NLM012627046
|x 1940-9818
|7 nnas
|
773 |
1 |
8 |
|g volume:73
|g year:2022
|g number:6
|g day:01
|g month:12
|g pages:289-296
|
856 |
4 |
0 |
|u http://dx.doi.org/10.2144/btn-2022-0048
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_21
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_39
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_50
|
912 |
|
|
|a GBV_ILN_60
|
912 |
|
|
|a GBV_ILN_62
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_99
|
912 |
|
|
|a GBV_ILN_121
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_227
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_618
|
912 |
|
|
|a GBV_ILN_640
|
912 |
|
|
|a GBV_ILN_754
|
912 |
|
|
|a GBV_ILN_2001
|
912 |
|
|
|a GBV_ILN_2002
|
912 |
|
|
|a GBV_ILN_2003
|
912 |
|
|
|a GBV_ILN_2005
|
912 |
|
|
|a GBV_ILN_2006
|
912 |
|
|
|a GBV_ILN_2007
|
912 |
|
|
|a GBV_ILN_2008
|
912 |
|
|
|a GBV_ILN_2009
|
912 |
|
|
|a GBV_ILN_2010
|
912 |
|
|
|a GBV_ILN_2012
|
912 |
|
|
|a GBV_ILN_2015
|
912 |
|
|
|a GBV_ILN_2018
|
912 |
|
|
|a GBV_ILN_2023
|
912 |
|
|
|a GBV_ILN_2035
|
912 |
|
|
|a GBV_ILN_2040
|
912 |
|
|
|a GBV_ILN_2060
|
912 |
|
|
|a GBV_ILN_2099
|
912 |
|
|
|a GBV_ILN_2105
|
912 |
|
|
|a GBV_ILN_2121
|
912 |
|
|
|a GBV_ILN_2470
|
951 |
|
|
|a AR
|
952 |
|
|
|d 73
|j 2022
|e 6
|b 01
|c 12
|h 289-296
|